3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
29
fludarabine
19
fludarabine phosphate
13
Methotrexate
12
blinatumomab
11
Whole-Body Irradiation
11
Vincristine
8
Tacrolimus
8
Mycophenolic Acid
8
Cytarabine
8
Dexamethasone
7
Cyclosporine
7
Busulfan
7
merphos
6
Thiotepa
6
Specimen Handling
6
Mercaptopurine
6
Melphalan
6
Granulocyte Colony-Stimulating Factor
6
pegaspargase
5
Peripheral Blood Stem Cell Transplantation
5
Mesna
5
Filgrastim
5
venetoclax
4
prednylidene
4
Stem Cell Transplantation
4
Sirolimus
4
Prednisone
4
Leukapheresis
4
Immunotherapy, Adoptive
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
2C4 antibody
×
30 days
×
Clear all
No trials found.